Truvestments Capital’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$894K Buy
2,540
+31
+1% +$11.1K 0.16% 148
2025
Q4
$821K Sell
2,509
-154
-6% -$48.9K 0.15% 138
2025
Q3
$751K Buy
2,663
+1,443
+118% +$418K 0.14% 141
2025
Q2
$341K Buy
1,220
+115
+10% +$32.6K 0.07% 196
2025
Q1
$344K Buy
1,105
+314
+40% +$92.7K 0.07% 178
2024
Q4
$206K Buy
791
+69
+10% +$20.5K 0.05% 215
2024
Q3
$233K Sell
722
-991
-58% -$324K 0.06% 201
2024
Q2
$535K Buy
1,713
+601
+54% +$177K 0.21% 107
2024
Q1
$316K Buy
1,112
+14
+1% +$4.1K 0.12% 160
2023
Q4
$316K Buy
+1,098
New +$299K 0.14% 150
2023
Q1
Sell
-4
Closed -$1.05K 684
2022
Q4
$1.05K Buy
+4
New +$1.07K ﹤0.01% 819
2021
Q2
Sell
-55
Closed -$14K 622
2021
Q1
$14K Hold
55
0.01% 405
2020
Q4
$13K Hold
55
0.01% 398
2020
Q3
$14K Sell
55
-8
-13% -$1.98K 0.01% 241
2020
Q2
$14K Hold
63
0.01% 344
2020
Q1
$12K Buy
+63
New +$13.8K 0.02% 323
2019
Q4
Sell
-32
Closed -$6K 160
2019
Q3
$6K Sell
32
-97
-75% -$18.6K ﹤0.01% 547
2019
Q2
$24K Sell
129
-123
-49% -$22K 0.02% 390
2019
Q1
$48K Buy
+252
New +$48.1K 0.04% 280
2018
Q3
$52K Buy
+250
New +$49.3K 0.03% 378

Other funds holding AMGN

Truvestments Capital's AMGN Position: Q1 2026 in Review

Truvestments Capital increased its Amgen (AMGN) stake by 1.2% in Q1 2026, buying an estimated $11.1K and bringing the position to 2,540 shares worth $894K. The position accounts for 0.16% of the portfolio, ranked #148.

Truvestments Capital first reported a position in AMGN in Q3 2018 and has held it in 20 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Truvestments Capital held 2,540 shares of Amgen worth $894K as of Q1 2026.
  • Truvestments Capital bought 31 Amgen shares in Q1 2026, an estimated $11.1K.
  • Amgen made up 0.16% of Truvestments Capital's portfolio in Q1 2026, its #148 holding.
  • Truvestments Capital first reported a position in Amgen in Q3 2018 and has held it in 20 quarters since.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.